Search results

Journal Article (143)

  1. Journal Article
    Lindner, L. H.; Eichhorn, M. E.; Eibl, H.; Teichert, N.; Schmitt-Sody, M.; Issels, R. D.; Dellian, M.: Novel temperature-sensitive liposomes with prolonged circulation time. Clinical Cancer Research 10 (6), pp. 2168 - 2178 (2004)
  2. Journal Article
    Bommer, W.; Eibl, H.; Engel, K. R.; Kuhlencord, A.; Sindermann, H.; Sundar, S.; Zappel, H.: Leishmaniasis - Oral treatment with hexadecylphosphocholine. Wiener Klinische Wochenschrift 116 (Suppl. 4), pp. 24 - 29 (2004)
  3. Journal Article
    Erdlenbruch, B.; Alipour, M.; Fricker, G.; Miller, D. S.; Kugler, W.; Eibl, H.; Lakomek, M.: Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. British Journal of Pharmacology 140 (7), pp. 1201 - 1210 (2003)
  4. Journal Article
    Sindermann, H.; Croft, S. L.; Engel, K. R.; Bommer, W.; Eibl, H.; Unger, C.; Engel, J.: Miltefosine (Impavido): the first oral treatment against leishmaniasis. Medical Microbiology and Immunology online, 10.1007/s00430-003-0201-2 (2003)
  5. Journal Article
    Erdlenbruch, B.; Schinkhof, C.; Kugler, W.; Heinemann, D.; Herms, J.; Eibl, H.; Lakomek, M.: Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain. British Journal of Pharmacology 139 (4), pp. 685 - 694 (2003)
  6. Journal Article
    Jendrossek, V.; Mueller, I.; Eibl, H.; Belka, C.: Intracellular mediators of erucylphosphocholine-induced apoptosis. Oncogene 22 (17), pp. 2621 - 2632 (2003)
  7. Journal Article
    Lehnert, R.; Eibl, H.; Mueller, K.: FT-IR and NMR studies on the conformational and structural properties of 1,2 Dipalmitoyl-sn-glycero-3-phosphatidyloligoglycerols. Journal of Physical Chemistry 107 B, pp. 75 - 85 (2003)
  8. Journal Article
    Walochnik, J.; Duchene, M.; Eibl, H.; Aspock, H.: Treatment of Acanthamoeba keratitis: standard, problems, and new approaches. Wiener Klinische Wochenschrift 115 (Suppl. 3), pp. 10 - 17 (2003)
  9. Journal Article
    Erdlenbruch, B.; Jendrossek, V.; Kugler, W.; Eibl, H.; Lakomek, M.: Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats. Cancer Chemotherapy and Pharmacology 50 (4), pp. 299 - 304 (2002)
  10. Journal Article
    Kugler, W.; Erdlenbruch, B.; Junemann, A.; Heinemann, D.; Eibl, H.; Lakomek, M.: Erucylphosphocholine-induced apoptosis in glioma cells: involvement of death receptor signalling and caspase activation. Journal of Neurochemistry 82 (5), pp. 1160 - 1170 (2002)
  11. Journal Article
    Konstantinov, S. M.; Georgieva, M. C.; Topashka-Ancheva, M.; Eibl, H.; Berger, M. R.: Combination with an antisense oligonucleotide synergistically improves the antileukemic efficacy of erucylphospho-N,N,N- trimethylpropylammonium in chronic myeloid leukemia cell lines. Molecular Cancer Therapeutics 1 (10), pp. 877 - 884 (2002)
  12. Journal Article
    Jendrossek, V.; Hammersen, K.; Erdlenbruch, B.; Kugler, W.; Krugener, R.; Eibl, H.; Lakomek, M.: Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro. Cancer Chemotherapy and Pharmacology 50 (1), pp. 71 - 79 (2002)
  13. Journal Article
    Walochnik, J.; Duchene, M.; Seifert, K.; Obwaller, A.; Hottkowitz, T.; Wiedermann, G.; Eibl, H.; Aspock, H.: Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrobial Agents and Chemotherapy 46 (3), pp. 695 - 701 (2002)
  14. Journal Article
    Jendrossek, V.; Kugler, W.; Erdlenbruch, B.; Eibl, H.; Lang, F.; Lakomek, M.: Erucylphosphocholine-induced apoptosis in chemoresistant glioblastoma cell lines: Involvement of caspase activation and mitochondrial alterations. Anticancer Research 21 (5), pp. 3389 - 3396 (2001)
  15. Journal Article
    Thaler, A.; Hottkowitz, T.; Eibl, H.: Separation and quantification of alkylphosphocholines by reversed phase high performance liquid chromatography. Chemistry and Physics of Lipids 107, pp. 131 - 139 (2000)
  16. Journal Article
    Bommer, W.; Eibl, H.; Kuhlencord, A.; Zappel, H.: Clinical experiences with cutaneous and visceral leishmaniasis - New strategies for therapy. Schweizerische Medizinische Wochenschrift 129, pp. 31 - 32 (1999)
  17. Journal Article
    Erdlenbruch, B.; Jendrossek, V.; Gerriets, A.; Vetterlein, F.; Eibl, H.; Lakomek, M.: Erucylphosphocholine: Pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration. Cancer Chemotherapy and Pharmacology 44, pp. 484 - 490 (1999)
  18. Journal Article
    Jendrossek, V.; Erdlenbruch, B.; Hunold, A.; Kugler, W.; Eibl, H.; Lakomek, M.: Erucylphosphocholine, a novel antineoplastic either lipid, blocks growth and induces apoptosis in brain tumor cell lines in vitro. International Journal of Oncology 14, pp. 15 - 22 (1999)
  19. Journal Article
    Konstantinov, S. M.; Eibl, H.; Berger, M. R.: BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines. British Journal of Haematology 107, pp. 365 - 374 (1999)
  20. Journal Article
    Lindner, L. H.; Thaler, A.; Eibl, H.: Requirement of DOPE as ’helper lipid‘ in novel cationic liposomes depends strongly on DNA size and cationic lipid structure. European Journal of Cancer 35 (Suppl. 5), p. 37 (1999)
Go to Editor View